Virtual vs In-Person Neurologic Ambulatory Care
Neurology Minute
Dr. Greg Cooper and Dr. Chloe Hill discuss comparing virtual and in-person neurology outpatient visits for new patients. Show citation: Hill CE, Lin CC, Harris A, et al. Virtual vs In-Person Neurologic Ambulatory Care: A Case-Control Study of Subsequent Health Care Utilization. Neurology. 2026;106(10):e214989. doi:
info_outline
Lab Minute: Tolosa Hunt Syndrome
Neurology Minute
In this lab minute, Dr. Stacey Clardy discusses Tolosa Hunt syndrome
info_outline
Consortium of Neurology Residents and Fellows
Neurology Minute
Dr. Margarita Fedorova talks with Dr. Sunanjay Bajaj about the Consortium of Neurology Residents and Fellows (CNRF). Visit the AAN website to learn more about the . Connect with the .
info_outline
Vamorolone for Duchenne Muscular Dystrophy
Neurology Minute
Dr. Aaron Zelikovich discusses the efficacy and anthropometric effect of vamorolone with prednisone and deflazacort. Show citation: Clemens PR, Berglund A, Schiava M, et al. Vamorolone for Duchenne Muscular Dystrophy: A Cross-Trial Efficacy Comparison With Classic Corticosteroids From the FOR-DMD Trial. Neurology. 2026;107(1):e214756. doi:
info_outline
American Epilepsy Society Clinical Practice Guideline - Part 1
Neurology Minute
In part one of this series, Dr. Dara Albert and Dr. Daniel Freedman share their key takeaways from the recent guideline. Show citation: Freedman D, Babatunde I, Morgan RL, et al. American Epilepsy Society Clinical Practice Guideline: Infantile Epilepsy. Epilepsy Curr. 2026;26(3):174-202. Published 2026 Apr 8. doi:
info_outline
Post-Traumatic Headache in Children and Genetic Risk of Migraine
Neurology Minute
Dr. Jessica Ailani and Dr. Serena Orr discuss the genetic risk of migraine and post-traumatic headache in children. Show citation: Orr SL, Hershey AD, Kurowski BG, et al. Post-Traumatic Headache in Children and Genetic Risk of Migraine: An Observational Cohort Study. Neurol Genet. 2026;12(2):e200371. Published 2026 Apr 1. doi:
info_outline
Efficacy and Safety of Cemdisiran siRNA in Myasthenia Gravis
Neurology Minute
Dr. Aaron S. Zelikovich discusses the phase 3 NIMBLE trial of cemdisiran, an siRNA targeting complement component 5, for the treatment of generalized myasthenia gravis. Show citation: Vu T, Habib AA, Jacob S, et al. Efficacy and safety of cemdisiran siRNA in myasthenia gravis (NIMBLE): a double-blind, randomised, placebo-controlled, phase 3 trial. Lancet. 2026;407(10540):1712-1725. doi:
info_outline
Negative Myoclonus
Neurology Minute
Dr. Zohaib Siddiqi shares clinical pearls on negative myoclonus.
info_outline
An Update on Troriluzole
Neurology Minute
Dr. Margarita Fedorova discusses the use of troriluzole for spinocerebellar ataxia. Show citations:
info_outline
The Current State of Diagnostics for Neuroimmunologic Disorders in Africa
Neurology Minute
Drs. Paul Crane, Fiifi Duodu, and Malya Sahu discuss neuroimmunology and multiple sclerosis diagnosis in Africa, including challenges and efforts to improve care. Show citation: Sahu M, Chomba M, Duodu F, Diaz MM, Sokhi D, Saylor D. The Current State of Diagnostics for Neuroimmunological Disorders in Africa. J Cent Nerv Syst Dis. 2025;17:11795735251385319. Published 2025 Nov 19. doi:
info_outlineIn this episode of Neurology Minute, Dr. Stacey Clardy discusses Amyloidosis.
Show reference:
https://doi.org/10.1111/imj.15974